CBRNe Primer

Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNe) threats are no longer theoretical - they are real, immediate, and growing. Heligan’s CBRNe Primer highlights key risks, case studies, and a rapidly expanding market projected to exceed $21bn in Europe by 2027, offering critical insights for governments, industry, and investors.